TLPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
TALPHERA, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$1.08+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $81.57M
- P/E (TTM)
- –
- Dividend yield
- –
TALPHERA, INC. revenue by segment
By business segment
By product or service
| Revenue | TTM Q4 22 | TTM Q3 22 | TTM Q2 22 | TTM Q1 22 | TTM Q4 21 | TTM Q3 21 | TTM Q2 21 | TTM Q1 21 | TTM Q4 20 | TTM Q3 20 | TTM Q2 20 | TTM Q1 20 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product [Member] | $1.77M | $1.52M | $1.17M | $996.00K | $1.01M | $1.66M | $2.79M | $2.70M | $2.52M | $2.24M | $1.51M | $1.98M | 50.0% | +76.2% |
| DSUVIA [Member] | $1.59M | $1.37M | $1.05M | $996.00K | $735.00K | $1.05M | $1.83M | $1.44M | $1.41M | – | – | – | 44.8% | +116.1% |
| DZUVEO [Member] | $183.00K | – | – | – | – | – | – | – | – | – | – | – | 5.2% | – |
| Contract and Other Collaboration [Member] | $0 | $0 | $1.70M | $1.75M | $1.81M | $1.89M | $273.00K | $2.84M | $2.90M | $2.91M | $2.88M | $432.00K | 0.0% | -100.0% |
| Amended License Agreement [Member] | – | – | – | – | – | $2.31M | $961.00K | $3.83M | $3.68M | $3.56M | $3.65M | $1.51M | – | – |
| DSUVIA [Member] | – | – | – | – | – | – | – | $1.44M | $1.41M | $1.25M | $432.00K | $485.00K | – | – |
| ZALVISO [Member] | – | – | – | $0 | $270.00K | $610.00K | $962.00K | $1.26M | $1.11M | $990.00K | $1.08M | $1.49M | – | – |
| Non-cash Royalty [Member] | – | – | – | $38.00K | $83.00K | $144.00K | $204.00K | $203.00K | $242.00K | $254.00K | $230.00K | $311.00K | – | – |
| Royalty [Member] | – | – | – | $13.00K | $28.00K | $48.00K | $69.00K | $68.00K | $81.00K | $86.00K | $77.00K | $105.00K | – | – |
| Contract and Other Revenue [Member] | – | – | – | – | $6.00K | – | – | – | $2.57M | – | – | – | – | – |
| License [Member] | – | – | – | – | $1.70M | – | – | – | – | – | – | – | – | – |
By region
From the segment and revenue-disaggregation notes of Talphera's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.